CD8+ effector T cells in tumor tissues were also analyzed by flow cytometry and immunostaining, as dramatic changes in CD8+ T cell population were observed upon scRNA-seq analysis after V-Navo@gel treatment. The gene discussed is CD8A; the disease is neoplasm.